The analysis of low cost medicine's accessibility in China: Based on the empirical study from 24 provinces and cities
10.3969/j.issn.1674-2982.2018.03.013
- VernacularTitle:我国低价药品可及性现状分析:来自全国24个省/市的实证研究
- Author:
Wen-Wen DU
1
;
Wei XU
;
Gong-Jie CAI
;
Li MA
Author Information
1. 中国药科大学国际医药商学院 江苏南京 211198
- Keywords:
Low cost medicine;
Accessibility;
Empirical study
- From:
Chinese Journal of Health Policy
2018;11(3):72-77
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze the satiation of low cost medicine at present and provide suggestions for im-proving the low cost medicine policy since it has been conducted. Methods: The article uses the statistics from 24 provinces and cities to analyse the accessibility of low cost medicine with the angles of general condition,procurability and affordability. Results:The accessibility of low cost medicine is high through its policy knowledge is low. For pro-curability, there are only part of low cost medicine lacking in several areas momently; for affordability, the price of low cost medicine is affordable even through its price has been raised after the performance of policy. The reasons for shortage includes low price,check price transaction,lack of raw and processed material and small quantity demand of some medicine,etc. Conclusions:We suggest that government should improve the knowledge of this policy in hospi-tals and encourage low cost medicine in clinical applications. It also should lead companies to set the appropriate price and refine the purchasing system which will avoid the too high or too low price and help to ensure the amount and standard of companies that be selected in purchasing online. At the same time, government is supposed to strengthen the supervision on supply chain of low cost medicine and establish the communication mechanism for sup-ply system in order to guarantee the regulated supply of low cost medicine.
